Xcout Intel
Kijimea
Kijimea, developed by SYNformulas GmbH and headquartered near Munich in Gräfelfing, Germany, is a pioneer in producing leading products for irritable bowel syndrome.
The full profile of Kijimea
Funding, investors, leadership and board, hiring signals, tech stack and corporate events for this company are available inside Xcout Intel. Subscribe to open it.
Subscribe to see Kijimea →Already a subscriber? Sign in
Xcout Intel tracks Kijimea continuously — this profile deepens as new filings, funding, people and hiring data arrive.